Cargando…

Gastric antral vascular ectasia: the evolution of therapeutic modalities

Gastric Antral Vascular Ectasia (GAVE) may be an enigmatic source of non-variceal upper GI bleeding associated with various systemic diseases such as connective tissue disorders, liver disease, and chronic renal failure. Successful treatment of GAVE continues to be a challenge and has evolved throug...

Descripción completa

Detalles Bibliográficos
Autores principales: Naidu, Harini, Huang, Qin, Mashimo, Hiroshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: © Georg Thieme Verlag KG 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4423327/
https://www.ncbi.nlm.nih.gov/pubmed/26135263
http://dx.doi.org/10.1055/s-0034-1365525
_version_ 1782370196405616640
author Naidu, Harini
Huang, Qin
Mashimo, Hiroshi
author_facet Naidu, Harini
Huang, Qin
Mashimo, Hiroshi
author_sort Naidu, Harini
collection PubMed
description Gastric Antral Vascular Ectasia (GAVE) may be an enigmatic source of non-variceal upper GI bleeding associated with various systemic diseases such as connective tissue disorders, liver disease, and chronic renal failure. Successful treatment of GAVE continues to be a challenge and has evolved through the years. Currently, given the rapid response, safety, and efficacy, endoscopic ablative modalities have largely usurped medical treatments as first-line therapy, particularly using argon plasma coagulation. However, other newer ablative modalities such as radiofrequency ablation, cryotherapy, and band ligations are promising. This paper is an overview of GAVE and its various endoscopic and medical therapies.
format Online
Article
Text
id pubmed-4423327
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher © Georg Thieme Verlag KG
record_format MEDLINE/PubMed
spelling pubmed-44233272015-06-23 Gastric antral vascular ectasia: the evolution of therapeutic modalities Naidu, Harini Huang, Qin Mashimo, Hiroshi Endosc Int Open Article Gastric Antral Vascular Ectasia (GAVE) may be an enigmatic source of non-variceal upper GI bleeding associated with various systemic diseases such as connective tissue disorders, liver disease, and chronic renal failure. Successful treatment of GAVE continues to be a challenge and has evolved through the years. Currently, given the rapid response, safety, and efficacy, endoscopic ablative modalities have largely usurped medical treatments as first-line therapy, particularly using argon plasma coagulation. However, other newer ablative modalities such as radiofrequency ablation, cryotherapy, and band ligations are promising. This paper is an overview of GAVE and its various endoscopic and medical therapies. © Georg Thieme Verlag KG 2014-06 2014-05-15 /pmc/articles/PMC4423327/ /pubmed/26135263 http://dx.doi.org/10.1055/s-0034-1365525 Text en © Thieme Medical Publishers
spellingShingle Article
Naidu, Harini
Huang, Qin
Mashimo, Hiroshi
Gastric antral vascular ectasia: the evolution of therapeutic modalities
title Gastric antral vascular ectasia: the evolution of therapeutic modalities
title_full Gastric antral vascular ectasia: the evolution of therapeutic modalities
title_fullStr Gastric antral vascular ectasia: the evolution of therapeutic modalities
title_full_unstemmed Gastric antral vascular ectasia: the evolution of therapeutic modalities
title_short Gastric antral vascular ectasia: the evolution of therapeutic modalities
title_sort gastric antral vascular ectasia: the evolution of therapeutic modalities
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4423327/
https://www.ncbi.nlm.nih.gov/pubmed/26135263
http://dx.doi.org/10.1055/s-0034-1365525
work_keys_str_mv AT naiduharini gastricantralvascularectasiatheevolutionoftherapeuticmodalities
AT huangqin gastricantralvascularectasiatheevolutionoftherapeuticmodalities
AT mashimohiroshi gastricantralvascularectasiatheevolutionoftherapeuticmodalities